Published in Scand J Gastroenterol on January 01, 2009
Improvement in Stress, General Self-Efficacy, and Health Related Quality of Life following Patient Education for Patients with Neuroendocrine Tumors: A Pilot Study. Nurs Res Pract (2013) 0.85
Goblet cell carcinoid in a patient with neurofibromatosis type 1: a rare combination. Case Rep Gastrointest Med (2012) 0.83
Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumours. Ann Transl Med (2015) 0.79
ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours. ISRN Oncol (2013) 0.78
Surgery for small-bowel neuroendocrine tumors: is there any benefit of the laparoscopic approach? Surg Endosc (2014) 0.76
Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors. PLoS One (2016) 0.75
Rectal Mechano-sensory Function in Patients with Carcinoid Diarrhea. J Neurogastroenterol Motil (2016) 0.75
Incidence and survival of patients with small intestinal neuroendocrine tumours in a Danish NET center. ScientificWorldJournal (2012) 0.75
A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report. Onco Targets Ther (2015) 0.75
Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study. Oncotarget (2016) 0.75
The Influence of Preoperative Symptoms on the Death of Patients with Small Intestinal Neuroendocrine Tumors. Ann Surg Oncol (2016) 0.75
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc (2010) 4.26
Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol (2007) 2.68
Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet (2002) 2.12
Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol (2006) 1.90
Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology (2006) 1.69
ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell Oncol (2006) 1.48
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology (2006) 1.46
Abdominal complaints in general practice. Scand J Prim Health Care (2004) 1.45
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet (2010) 1.43
Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis. J Hepatol (2006) 1.42
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. Mol Cancer (2008) 1.31
Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci. J Hepatol (2012) 1.29
Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. Clin Gastroenterol Hepatol (2005) 1.29
DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset. PLoS One (2010) 1.26
Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas. Mol Cancer (2011) 1.22
Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol (2004) 1.20
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours. Acta Oncol (2010) 1.15
Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia. Scand J Gastroenterol (2007) 1.14
Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis (2005) 1.13
Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study. Scand J Gastroenterol Suppl (2006) 1.12
Hypermethylated MAL gene - a silent marker of early colon tumorigenesis. J Transl Med (2008) 1.11
Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology (2013) 1.11
Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis. BMC Gastroenterol (2004) 1.09
Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis (2006) 1.07
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. Acta Oncol (2014) 1.05
Gut microbiota diversity predicts immune status in HIV-1 infection. AIDS (2015) 1.05
Air and carbon dioxide volumes insufflated during colonoscopy. Gastrointest Endosc (2003) 1.02
Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci. Mol Cancer (2010) 1.01
Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease course. Scand J Gastroenterol (2007) 1.00
Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis. Eur J Gastroenterol Hepatol (2005) 0.97
Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome. PLoS One (2011) 0.94
Clinicians' attitudes towards endoscopic ultrasound: a survey of four European countries. Scand J Gastroenterol (2009) 0.94
Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: expert clinical opinion. J Crohns Colitis (2013) 0.93
Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis. Clin Gastroenterol Hepatol (2006) 0.91
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells. Arterioscler Thromb Vasc Biol (2012) 0.91
Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel Disease. Inflamm Bowel Dis (2007) 0.89
Capsule enteroscopy and radiology of the small intestine. Eur Radiol (2007) 0.89
Screening for GI cancer and payment mechanisms. Gastrointest Endosc (2002) 0.89
Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors. BMC Cancer (2010) 0.88
Image documentation of endoscopic findings in ulcerative colitis: photographs or video clips? Gastrointest Endosc (2005) 0.87
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma. Hepatology (2015) 0.87
How useful are the Rome II criteria for identification of upper gastrointestinal disorders in general practice? Scand J Gastroenterol (2005) 0.86
The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers. Int J Cancer (2014) 0.86
A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors. Clin Transl Gastroenterol (2012) 0.85
Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients. Scand J Gastroenterol (2011) 0.85
Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART. J Acquir Immune Defic Syndr (2015) 0.84
Temporal and spatial diversity of the tap water microbiota in a Norwegian hospital. Appl Environ Microbiol (2009) 0.83
Nitrous oxide for analgesia in colonoscopy without sedation. Gastrointest Endosc (2011) 0.83
Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article. Scand J Gastroenterol (2012) 0.83
Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy (SADE) in 907 ERCPs. Scand J Gastroenterol (2014) 0.82
Serum nutrients and habitual dietary intake in colectomized FAP patients in Norway. Eur J Nutr (2009) 0.82
Contemporary use of endoscopic retrograde cholangiopancreatography (ERCP): a Norwegian prospective, multicenter study. Scand J Gastroenterol (2011) 0.82
Familial adenomatous polyposis patients have high levels of arachidonic acid and docosahexaenoic acid and low levels of linoleic acid and alpha-linolenic acid in serum phospholipids. Int J Cancer (2007) 0.82
Effect of phenotype on health care costs in Crohn's disease: A European study using the Montreal classification. J Crohns Colitis (2007) 0.82
Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis. Neuroendocrinology (2010) 0.81
Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years. J Crohns Colitis (2007) 0.80
Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation. J Hepatol (2003) 0.80
Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP. Fam Cancer (2010) 0.80
Fatty acids in habitual diet, plasma phospholipids, and tumour and normal colonic biopsies in young colorectal cancer patients. J Oncol (2012) 0.79
APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations. J Cancer Res Clin Oncol (2009) 0.78
Gastronet survey on the use of one- or two-person technique for colonoscopy insertion. BMC Gastroenterol (2011) 0.78
Adenoma formation and malignancy after restorative proctocolectomy with or without mucosectomy in patients with familial adenomatous polyposis. Dis Colon Rectum (2013) 0.78
[Pain in connection with colonoscopy in Norway]. Tidsskr Nor Laegeforen (2013) 0.78
Proceedings of a preliminary workshop at Gastro 2009--narrow banding imaging in digestive endoscopy: clinical outcome of classification (Omed-Jges Educational Meeting held on 22 November, 2009). Dig Endosc (2011) 0.78
How to cannulate? A survey of the Scandinavian Association for Digestive Endoscopy (SADE) in 141 endoscopists. Scand J Gastroenterol (2012) 0.77
Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life. Am J Gastroenterol (2002) 0.77
[Irritable bowel syndrome--a multifactorial disease in children and adults]. Tidsskr Nor Laegeforen (2002) 0.77
Treatment of fulminant ulcerative colitis with cyclosporine A. Scand J Gastroenterol (2009) 0.77
Variability in the management of nonvariceal upper gastrointestinal bleeding in Europe: an observational study. Adv Ther (2012) 0.77
Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors. Scand J Gastroenterol (2014) 0.76
Patient-reported outcome measures after endoscopic retrograde cholangiopancreatography: a prospective, multicentre study. Scand J Gastroenterol (2013) 0.76
A national audit of temporal trends in endoscopic retrograde cholangiopancreatography in Norway. Scand J Gastroenterol (2010) 0.76
Paediatric Gastrointestinal Endoscopy: European Society for Paediatric Gastroenterology Hepatology and Nutrition and European Society of Gastrointestinal Endoscopy Guidelines. J Pediatr Gastroenterol Nutr (2017) 0.76
Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors. Endocr Connect (2013) 0.75
[From science fiction to clinica routine]. Tidsskr Nor Laegeforen (2005) 0.75
[Clinical use of COX inhibitors--a consensus]. Tidsskr Nor Laegeforen (2006) 0.75
Evaluation of right ventricular dysfunction by myocardial strain echocardiography in patients with intestinal carcinoid disease. J Am Soc Echocardiogr (2011) 0.75
Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease. Inflamm Bowel Dis (2017) 0.75
Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010. Neuroendocrinology (2015) 0.75
[Net-based guideline for anamnesis taking and clinical examination]. Tidsskr Nor Laegeforen (2009) 0.75
Cinical gastroenterology. Scand J Gastroenterol (2013) 0.75
Introducing a new executive editor, Professor Einar S.Bjørnsson. Scand J Gastroenterol (2013) 0.75
[Eosinophilic oesophagitis]. Tidsskr Nor Laegeforen (2011) 0.75
Randomized Controlled Trial of Laparoscopic and Open Nissen Fundoplication in Children. Ann Surg (2015) 0.75
Early anti-TNF treatment in pediatric Crohn's disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients. Scand J Gastroenterol (2014) 0.75
The influence of underweight and dietary support on well-being in lung transplant candidates. Respir Med (2005) 0.75
Are specific guidelines necessary for treatment of esophageal varices in the Nordic countries? Scand J Gastroenterol (2009) 0.75